MBX 2109

MBX-2109 · MBX Biosciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MBX 2109, covering 2025-10-28 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism [Phase 2]